Literature DB >> 20169436

[The relevance of magnetic resonance imaging (MRI) for the detection and exclusion of prostate cancer].

J Stattaus1, M Forsting.   

Abstract

This review illustrates the relevance of magnetic resonance imaging (MRI) for the detection or exclusion of prostate cancer. The functional MR methods dynamic contrast-enhanced MRI (DCE-MRI), MR spectroscopy, and diffusion-weighted imaging (DWI) helped in recent years to establish MRI as the imaging method of choice for prostate cancer. Indications for MRI of the prostate regarding recent guidelines and new concepts of cancer therapy are introduced.

Entities:  

Mesh：

Year:  2010        PMID： 20169436     DOI： 10.1007/s00120-010-2272-1

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


  29 in total

1.  MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies.

Authors:  Aristotelis G Anastasiadis; Matthias P Lichy; Udo Nagele; Markus A Kuczyk; Axel S Merseburger; Joerg Hennenlotter; Stefan Corvin; Karl-Dietrich Sievert; Claus D Claussen; Arnulf Stenzl; Heinz-Peter Schlemmer
Journal:  Eur Urol       Date:  2006-03-24       Impact factor: 20.096

2.  Per-sextant localization and staging of prostate cancer: correlation of imaging findings with whole-mount step section histopathology.

Authors:  Anno Graser; Andreas Heuck; Bernhard Sommer; Joerg Massmann; Juergen Scheidler; Maximillian Reiser; Ullrich Mueller-Lisse
Journal:  AJR Am J Roentgenol       Date:  2007-01       Impact factor: 3.959

3.  Magnetic resonance imaging-directed transrectal ultrasonography-guided biopsies in patients at risk of prostate cancer.

Authors:  Jean-Baptiste Lattouf; Robert L Grubb; S Justin Lee; Marc A Bjurlin; Paul Albert; Anurag K Singh; Iclal Ocak; Peter Choyke; Jonathan A Coleman
Journal:  BJU Int       Date:  2007-05       Impact factor: 5.588

4.  Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens.

Authors:  Philippe Puech; Eric Potiron; Laurent Lemaitre; Xavier Leroy; Georges-Pascal Haber; Sebastien Crouzet; Kazumi Kamoi; Arnauld Villers
Journal:  Urology       Date:  2009-09-20       Impact factor: 2.649

5.  Initial clinical experience with real-time transrectal ultrasonography-magnetic resonance imaging fusion-guided prostate biopsy.

Authors:  Anurag K Singh; Jochen Kruecker; Sheng Xu; Neil Glossop; Peter Guion; Karen Ullman; Peter L Choyke; Bradford J Wood
Journal:  BJU Int       Date:  2007-12-05       Impact factor: 5.588

Review 6.  [Magnetic resonance imaging in preoperative staging for breast cancer: pros and contras].

Authors:  C K Kuhl; M Braun
Journal:  Radiologe       Date:  2008-04       Impact factor: 0.635

Review 7.  Imaging prostate cancer: a multidisciplinary perspective.

Authors:  Hedvig Hricak; Peter L Choyke; Steven C Eberhardt; Steven A Leibel; Peter T Scardino
Journal:  Radiology       Date:  2007-04       Impact factor: 11.105

8.  Prostate cancer: is inapparent tumor at endorectal MR and MR spectroscopic imaging a favorable prognostic finding in patients who select active surveillance?

Authors:  Alvin R Cabrera; Fergus V Coakley; Antonio C Westphalen; Ying Lu; Shoujun Zhao; Katsuto Shinohara; Peter R Carroll; John Kurhanewicz
Journal:  Radiology       Date:  2008-05       Impact factor: 11.105

9.  Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT.

Authors:  Claudia Testa; Riccardo Schiavina; Raffaele Lodi; Eugenio Salizzoni; Barbara Corti; Mohsen Farsad; John Kurhanewicz; Fabio Manferrari; Eugenio Brunocilla; Caterina Tonon; Nino Monetti; Paolo Castellucci; Stefano Fanti; Manuela Coe; Walter F Grigioni; Giuseppe Martorana; Romeo Canini; Bruno Barbiroli
Journal:  Radiology       Date:  2007-07-24       Impact factor: 11.105

10.  Potential of magnetic resonance spectroscopic imaging in predicting absence of prostate cancer in men with serum prostate-specific antigen between 4 and 10 ng/ml: a follow-up study.

Authors:  Rajeev Kumar; Rishi Nayyar; Virendra Kumar; Narmada P Gupta; Ashok K Hemal; N R Jagannathan; S Dattagupta; S Thulkar
Journal:  Urology       Date:  2008-03-10       Impact factor: 2.649
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.